about
Selection for virulent dengue viruses occurs in humans and mosquitoesMouse models to study dengue virus immunology and pathogenesisA model of DENV-3 infection that recapitulates severe disease and highlights the importance of IFN-γ in host resistance to infectionLethal antibody enhancement of dengue disease in mice is prevented by Fc modificationInvasion and Maintenance of Dengue Virus Type 2 and Type 4 in the AmericasMurine Model for Dengue Virus-Induced Lethal Disease with Increased Vascular PermeabilityTranscriptional Activation of Interferon-Stimulated Genes but Not of Cytokine Genes after Primary Infection of Rhesus Macaques with Dengue Virus Type 1High Pro-Inflammatory Cytokine Secretion and Loss of High Avidity Cross-Reactive Cytotoxic T-Cells during the Course of Secondary Dengue Virus InfectionSpecific genetic markers for detecting subtypes of dengue virus serotype-2 in isolates from the states of Oaxaca and Veracruz, MexicoMolecular mechanisms of antibody-mediated neutralisation of flavivirus infectionClinical and laboratory features that distinguish dengue from other febrile illnesses in endemic populationsThe relationship of interacting immunological components in dengue pathogenesisEnhanced Infection of Liver Sinusoidal Endothelial Cells in a Mouse Model of Antibody-Induced Severe Dengue DiseaseA randomized controlled trial of chloroquine for the treatment of dengue in Vietnamese adultsPersistent dengue emergence: the 7 years surrounding the 2010 epidemic in Nepal.Meta-analysis of all immune epitope data in the Flavivirus genus: inventory of current immune epitope data status in the context of virus immunity and immunopathology.Development of DENVax: a chimeric dengue-2 PDK-53-based tetravalent vaccine for protection against dengue fever.Diabetes with hypertension as risk factors for adult dengue hemorrhagic fever in a predominantly dengue serotype 2 epidemic: a case control study.A variant in the CD209 promoter is associated with severity of dengue disease.Epidemiological trends of dengue disease in Mexico (2000-2011): a systematic literature search and analysis.Novel benzoxazole inhibitor of dengue virus replication that targets the NS3 helicase.Role of humoral versus cellular responses induced by a protective dengue vaccine candidate.Insights into HLA-restricted T cell responses in a novel mouse model of dengue virus infection point toward new implications for vaccine design.Dengue: where are we today?Variation in inflammatory/regulatory cytokines in secondary, tertiary, and quaternary challenges with dengue virus.The human antibody response to dengue virus infectionControversies in dengue pathogenesis.Preservation of a critical epitope core region is associated with the high degree of flaviviral cross-reactivity exhibited by a dengue-specific CD4+ T cell clone.Serum levels of interleukin-6, tumor necrosis factor-alpha and interferon-gamma in infants with and without dengue.Janus kinase/signal transducer and activator of transcription 3 signaling pathway is crucial in chemokine production from hepatocytes infected by dengue virus.Triggering of DC migration by dengue virus stimulation of COX-2-dependent signaling cascades in vitro highlights the significance of these cascades beyond inflammation.Differences in global gene expression in peripheral blood mononuclear cells indicate a significant role of the innate responses in progression of dengue fever but not dengue hemorrhagic fever.Infection of human dendritic cells by dengue virus activates and primes T cells towards Th0-like phenotype producing both Th1 and Th2 cytokines.Transplantation of a quaternary structure neutralizing antibody epitope from dengue virus serotype 3 into serotype 4.B cell subset alteration and the expression of tissue homing molecules in dengue infected patients
P2860
Q24558700-70712046-24BB-4C65-B0DD-92CBD55773D3Q27010151-DE2570B8-7C65-4219-A977-58EFA7D5AADEQ27305445-163C0CD7-13C2-4094-9D93-FE9DD9372B97Q27315772-A65ED5EA-0E04-47D4-9F68-C2DE73EE2ABFQ27472713-20131CF6-EFD5-4EA9-BCDA-C762AE9CA171Q27477548-AE2F32D9-2ECD-47EF-8487-D3EF1132A65AQ27480996-B4EA1B94-D64C-4500-9C9C-A6C60774B037Q27481682-2F819218-E3CF-49AF-ADF8-C7893E34CBAEQ27486634-81D40F61-4B77-426D-8AE6-A2CFB4B53C99Q27488337-B5DE3345-CCBF-4460-8830-CF1CB4CF66EDQ27489850-DDD1819B-5600-425A-8666-10A4C07A3F1CQ27490496-E64484FC-2A98-4ED5-A325-E6FEACD06437Q27490947-ABD5670A-24B6-459F-B60B-6A8753F35981Q28475036-266D88AC-90E3-4506-B773-DFF271BCE497Q30202261-CAF13D2F-039A-4ACD-AFEE-C9544CF3C94DQ33610555-7AB37B4A-F135-4470-BA4D-9CA49FD35004Q34202440-89DBD2AE-726D-4F9D-BA8A-5224993F7745Q34260245-20B5B150-1B44-4B05-BB5E-750A6DFE7746Q34412344-B6444457-F44C-491E-8119-D735C31D507DQ34464820-54E37878-3FAA-419C-95A2-BC825292500DQ34583461-CC2EE6A7-50D1-4EE0-AC62-D279EF0FA1F7Q35034240-D824504F-3D06-4DE2-962B-587E7B39930EQ35268996-FE1F15A2-33A5-4C65-8A80-3A00AA3D14C4Q35896391-AD853204-2857-4D28-B75C-BE5512002F90Q36213311-5574EBBD-2C2C-43D6-8D09-CE9FD60E8840Q37987124-8A65F1F2-A72C-4FA8-A94D-38996E7B0DB3Q38016235-8078ACC6-426F-4FA9-9067-491EECE68B38Q39267118-7501E0D0-1586-4741-9738-030A582F7D96Q39393893-34DBFE5F-FE04-4746-9FDD-83261EB5A01FQ40313101-177C3402-BAB3-4F9B-8435-D6AC6225ACDBQ40375409-D7A74D7D-8A85-4C41-B7FA-3B938AFCED4AQ40420543-808DE8D4-AD17-40AA-8646-343D12EC2197Q40518160-BA0AF732-448F-4E6E-8E80-51F939A89B24Q45323668-BBA42E85-8495-4ECC-8520-CE963FD0227EQ58701074-AE39AC79-B984-4801-B1DD-BE133F9AE3B1
P2860
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Immunology and immunopathogenesis of dengue disease.
@ast
Immunology and immunopathogenesis of dengue disease.
@en
type
label
Immunology and immunopathogenesis of dengue disease.
@ast
Immunology and immunopathogenesis of dengue disease.
@en
prefLabel
Immunology and immunopathogenesis of dengue disease.
@ast
Immunology and immunopathogenesis of dengue disease.
@en
P1476
Immunology and immunopathogenesis of dengue disease.
@en
P304
P356
10.1016/S0065-3527(03)60010-2
P577
2003-01-01T00:00:00Z